Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Visual Acuity Outcomes in Socioeconomically Disadvantaged Patients With Vitreous Hemorrhage Resulting From Proliferative Diabetic Retinopathy Treated at a County Hospital.

Journal of vitreoretinal diseases·2026

Same author

Leveraging Cell-Free Supernatants of Phyllospheric Bacteria to Combat Wheat Pathogens and Boost Growth.

Plant-environment interactions (Hoboken, N.J.)·2025

Same author

Microbiota transplantation for cotton leaf curl disease suppression-core microbiome and transcriptome dynamics.

Communications biology·2025

Same author

Disease Resistance Correlates with Core Microbiome Diversity in Cotton.

Current microbiology·2024

Same author

Microbial influencers and cotton leaf curl disease (CLCuD) susceptibility: a network perspective.

Frontiers in microbiology·2024

Same author

Patellar tendon biomechanical and morphologic properties and their relationship to serum clinical variables in persons with prediabetes and type 2 diabetes.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2024

Search research articles

Related Experiment Video

Updated: Aug 30, 2025

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

BILATERAL CYSTOID MACULAR EDEMA AFTER BIMATOPROST IMPLANTS.

Shivam H Patel¹, Ayesha Badar, Saaquib Bakhsh

¹Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana.

Retinal Cases & Brief Reports

|August 26, 2022

Summary

Bimatoprost implant (Durysta) injections for glaucoma may cause cystoid macular edema. Patients experiencing vision loss after receiving the implant should be monitored for this condition.

More Related Videos

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Published on: July 7, 2023

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Related Experiment Videos

Last Updated: Aug 30, 2025

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery

Published on: December 1, 2023

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Published on: July 7, 2023

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Area of Science:

Ophthalmology
Glaucoma treatment
Macular edema

Background:

Primary open-angle glaucoma is a progressive optic neuropathy.
Bimatoprost implant (Durysta) is a sustained-release formulation for glaucoma management.

Observation:

A case report details a 93-year-old woman treated with bilateral bimatoprost implants for primary open-angle glaucoma.
The patient experienced decreased visual acuity in both eyes following the injections.

Findings:

Bilateral cystoid macular edema was diagnosed as the cause of vision loss.
The condition improved with topical corticosteroid treatment.

Implications:

Bimatoprost implant (Durysta) may induce cystoid macular edema in some patients.
Post-injection monitoring for visual acuity decline is crucial, especially in high-risk individuals.